Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia

References

• Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37(3):240–249.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40(2):102–111.
   PubMed Web of Science ®Google Scholar
• Alexander BT, Cockrell KL, Massey MB, et al. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens. 2002;15(2 Pt 1):170–175.
   PubMed Web of Science ®Google Scholar
• LaMarca B, Wallukat G, Llinas M, et al. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008;52(6):1168–1172.
   PubMed Web of Science ®Google Scholar
• LaMarca BB, Bennett WA, Alexander BT, et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005;46(4):1022–1025.
   PubMed Web of Science ®Google Scholar
• LaMarca BB, Cockrell K, Sullivan E, et al. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46(1):82–86.
   PubMed Web of Science ®Google Scholar
• Parrish MR, Murphy SR, Rutland S, et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens. 2010;23(8):911–916. .
   PubMed Web of Science ®Google Scholar
• LaMarca B, Cornelius DC, Harmon AC, et al. Identifying immune mechanisms mediating the hypertension during preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2016;311(1):R1–9. .
   PubMed Web of Science ®Google Scholar
• Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70(2):427–451.
   PubMed Web of Science ®Google Scholar
• Ramseyer VD, Garvin JL. Tumor necrosis factor-alpha: regulation of renal function and blood pressure. Am J Physiol Renal Physiol. 2013;304(10):F1231–42.
   PubMed Web of Science ®Google Scholar
• Gutkowska J, Granger JP, Lamarca BB, et al. Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. J Hypertens. 2011;29(6):1203–1212.
   PubMed Web of Science ®Google Scholar
• Lefer AM, Ma XL. Cytokines and growth factors in endothelial dysfunction. Crit Care Med. 1993;21(2 Suppl):S9–14.
   PubMed Web of Science ®Google Scholar
• Wang P, Ba ZF, Chaudry IH. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol. 1994;266(6 Pt 2):H2535–41.
   PubMedGoogle Scholar
• LaMarca B, Speed J, Fournier L, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension. 2008;52(6):1161–1167. .
   PubMed Web of Science ®Google Scholar
• Murphy SR, LaMarca BB, Parrish M, et al. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alpha. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R130–5.
   PubMed Web of Science ®Google Scholar
• Emi Aikawa N, de Carvalho JF, Artur Almeida Silva C, et al. Immunogenicity of Anti-TNF-alpha agents in autoimmune diseases. Clin Rev Allergy Immunol. 2010;38(2–3):82–89.
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Otcheretianski-Volodarsky A, Shechtman S, et al. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol. 2014;43:78–84.
   PubMed Web of Science ®Google Scholar
• Cunningham MW Jr., Vaka VR, McMaster K, et al. Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy. Pregnancy Hypertens. 2019;15:72–77.
   PubMed Web of Science ®Google Scholar
• Vaka VR, Cunningham MW, Deer E, et al. Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2020;318(2):R256–R62. .
   PubMed Web of Science ®Google Scholar
• Elfarra J, Amaral LM, McCalmon M, et al. Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure. Clin Sci. 2017;131(23):2753–2762. .
   PubMed Web of Science ®Google Scholar
• Vaka VR, McMaster KM, Cornelius DC, et al. Natural killer cells contribute to mitochondrial dysfunction in response to placental ischemia in reduced uterine perfusion pressure rats. Am J Physiol Regul Integr Comp Physiol. 2019;316(5):R441–R7. .
   PubMed Web of Science ®Google Scholar
• Cunningham MW Jr., Castillo J, Ibrahim T, et al. AT1-AA (Angiotensin II type 1 receptor agonistic autoantibody) blockade prevents preeclamptic symptoms in placental ischemic rats. Hypertension. 2018;71(5):886–893. .
   PubMed Web of Science ®Google Scholar
• LaMarca B, Amaral LM, Harmon AC, et al. Placental ischemia and resultant phenotype in animal models of preeclampsia. Curr Hypertens Rep. 2016;18(5):38.
   PubMed Web of Science ®Google Scholar
• Cunningham MW Jr., Williams JM, Amaral L, et al. Agonistic autoantibodies to the angiotensin II type 1 receptor enhance angiotensin ii-induced renal vascular sensitivity and reduce renal function during pregnancy. Hypertension. 2016;68(5):1308–1313. .
   PubMed Web of Science ®Google Scholar
• Lu F, Bytautiene E, Tamayo E, et al. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol. 2007;197(4):418e1–5. .
   Web of Science ®Google Scholar
• Elfarra JT, Cottrell JN, Cornelius DC, et al. 17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug. Pregnancy Hypertens. 2020;318:R256-R262.
   Google Scholar
• Nielsen OH, Loftus EV Jr., Jess T. Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review. BMC Med. 2013 Jul 31;11:174. .
   PubMed Web of Science ®Google Scholar
• Vaka VR, McMaster KM, Cunningham MW Jr., et al. Role of mitochondrial dysfunction and reactive oxygen species in mediating hypertension in the reduced uterine perfusion pressure rat model of preeclampsia. Hypertension. 2018;72(3):703–711. .
   PubMed Web of Science ®Google Scholar
• Chiusolo V, Jacquemin G, Yonca Bassoy E, et al. Granzyme B enters the mitochondria in a Sam50-, Tim22- and mtHsp70-dependent manner to induce apoptosis. Cell Death Differ. 2017;24(4):747–758. .
   PubMed Web of Science ®Google Scholar
• Andrade F, Roy S, Nicholson D, et al. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity. 1998;8(4):451–460.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Chaparro M. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. Am J Gastroenterol. 2013 Sep;108(9):1426–1438.
   PubMed Web of Science ®Google Scholar
• Conigliaro P, Triggianese P, Perricone C, et al. Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment. Clin Exp Immunol. 2014;177(1):234–243. .
   PubMed Web of Science ®Google Scholar
• Jerzak M, Ohams M, Gorski A, et al. Etanercept immunotherapy in women with a history of recurrent reproductive failure. Ginekol Pol. 2012;83(4):260–264.
   PubMed Web of Science ®Google Scholar